ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models
February 25, 2021
DUBLIN, IRELAND & BARCELONA, SPAIN February 16, 2021 ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy, and biomedical relevance of new compounds, today announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
ZeClinics supports academic, pharmaceutical and biotech organizations in pre-clinical studies by providing services based on its zebrafish disease models. The Company is applying CRISPR/Cas9 technology to create single knock-out, double knock-out, and somatic F0 knock-out zebrafish variants.
G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual
Federal A: Gimnasia cerró su primera semana de entrenamientos más intensos analisisdigital.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from analisisdigital.com.ar Daily Mail and Mail on Sunday newspapers.
Municipalityâs letter published in full
Feb 17, 2021
JUNIATA TERRACE Juniata Terrace Borough Council has composed a letter, which it sent to both Lewistown Borough Council and the Municipal Authority of the Borough of Lewistown. A copy of the letter was sent to The Sentinel for publication.
The full text of the letter, dated Feb 10, appears below in italics.
The Borough of Juniata Terrace is reaching out to state our disappointment from the recent actions that have taken place on behalf of the Lewistown Borough Council and the Water Authority (MABL). It was our impression that a Memorandum of Understanding had been brokered to transfer the assets of MABL to create the Mifflin County Water Authority, which by doing so would have benefitted each of our municipalities that offer the services of the Water Authority to our residents. We were understanding of the profit that Lewistown Borough would gain from this agreement, and showed full support of this plan due to it being an
ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement
ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy and biomedical relevance of new compounds, today announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics CRISPR/Cas9 patent portfolio.
ZeClinics supports academic, pharmaceutical and biotech organizations in pre-clinical studies by providing services based on its zebrafish disease models. The Company is applying CRISPR/Cas9 technology to create single knock-out, double knock-out and somatic F0 knock-out zebrafish variants.